These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2419435

  • 1. Immunotherapy for myasthenia gravis: a murine model.
    Christadoss P, Dauphinee MJ.
    J Immunol; 1986 Apr 01; 136(7):2437-40. PubMed ID: 2419435
    [Abstract] [Full Text] [Related]

  • 2. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ, Oshima M, Deitiker P.
    Crit Rev Immunol; 2001 Apr 01; 21(1-3):1-27. PubMed ID: 11642597
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Animal models of myasthenia gravis.
    Christadoss P, Poussin M, Deng C.
    Clin Immunol; 2000 Feb 01; 94(2):75-87. PubMed ID: 10637092
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
    Christadoss P, Lindstrom JM, Talal N, Duvic CR, Kalantri A, Shenoy M.
    J Immunol; 1986 Sep 15; 137(6):1845-9. PubMed ID: 2943805
    [Abstract] [Full Text] [Related]

  • 10. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
    Wofsy D.
    J Immunol; 1986 Jun 15; 136(12):4554-60. PubMed ID: 3086436
    [Abstract] [Full Text] [Related]

  • 11. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S, Galin FS, Kishimoto M, Adachi A, Blalock JB.
    J Immunol; 1996 Jul 01; 157(1):386-92. PubMed ID: 8683141
    [Abstract] [Full Text] [Related]

  • 12. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.
    Kaul R, Shenoy M, Goluszko E, Christadoss P.
    J Immunol; 1994 Mar 15; 152(6):3152-7. PubMed ID: 8144909
    [Abstract] [Full Text] [Related]

  • 13. IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis.
    Shenoy M, Baron S, Wu B, Goluszko E, Christadoss P.
    J Immunol; 1995 Jun 01; 154(11):6203-8. PubMed ID: 7751658
    [Abstract] [Full Text] [Related]

  • 14. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D, Seaman WE.
    J Immunol; 1987 May 15; 138(10):3247-53. PubMed ID: 3106478
    [Abstract] [Full Text] [Related]

  • 15. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y, Meng F, Vincent A, van Breda Vriesman P, de Baets M.
    J Immunol; 1995 Jun 15; 154(12):6382-96. PubMed ID: 7539019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R, Wu B, Goluszko E, Deng C, Dedhia V, Nabozny GH, David CS, Rimm IJ, Shenoy M, Haqqi TM, Christadoss P.
    J Immunol; 1997 Jun 15; 158(12):6006-12. PubMed ID: 9190955
    [Abstract] [Full Text] [Related]

  • 18. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG, Duan RS, Zhu WH, Lu CZ.
    Cell Immunol; 2006 Jun 15; 241(2):95-101. PubMed ID: 17005165
    [Abstract] [Full Text] [Related]

  • 19. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G, Tarrab-Hazdai R, Teichberg VI.
    Eur J Immunol; 1983 Jun 15; 13(6):500-7. PubMed ID: 6861875
    [Abstract] [Full Text] [Related]

  • 20. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B, Deng C, Lee J, Christadoss P, Sarvetnick N.
    J Immunol; 1998 Sep 15; 161(6):2856-62. PubMed ID: 9743346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.